Giddi Pharma Co., Ltd.
↗Taichung, Taiwan
Giddi Pharma Co., Ltd. is a leading specialty pharmaceutical company based in Taiwan, founded in 1998. The company specializes in the commercial launch and distribution of orphan drugs, specialty products for pediatric genetic, metabolic, and neurological diseases, as well as hematology, oncology, transplantation, and orthopedic surgery products.
They provide a comprehensive 'one-stop' solution for global pharmaceutical partners looking to enter the Asia-Pacific market. Their services include product registration, insurance reimbursement, hospital formulary listing, pharmacovigilance, and cold-chain logistics. Giddi Pharma has established a strong reputation as a partner for global companies such as Genzyme, BioMarin, Shire, Ipsen, and Alexion.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Founded:1998
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Biologics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Genzyme (Distribution of rare disease drugs), BioMarin, Ipsen, Alexion, Shire
COMPETITION
Position:Leader
LEADERSHIP
Key Executives:
Louis Chiang - President
LINKS
Website:giddi.com.tw
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Giddi Pharma Co., Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Giddi Pharma Co., Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.